|
CNOT6L expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.57360000000639E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.840100E-04 |
| Normal-vs-Stage2 |
3.555500E-04 |
| Normal-vs-Stage3 |
3.64280000000328E-05 |
| Normal-vs-Stage4 |
4.766200E-04 |
| Stage1-vs-Stage2 |
2.219400E-01 |
| Stage1-vs-Stage3 |
1.470980E-01 |
| Stage1-vs-Stage4 |
3.389600E-01 |
| Stage2-vs-Stage3 |
8.787800E-01 |
| Stage2-vs-Stage4 |
7.958600E-01 |
| Stage3-vs-Stage4 |
8.892800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.383270E-04 |
| Normal-vs-AfricanAmerican |
1.061180E-01 |
| Normal-vs-Asian |
4.02550000000446E-05 |
| Caucasian-vs-AfricanAmerican |
4.121200E-01 |
| Caucasian-vs-Asian |
1.416620E-01 |
| AfricanAmerican-vs-Asian |
1.274790E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.628000E-04 |
| Normal-vs-Female |
5.56229999999491E-05 |
| Male-vs-Female |
8.200200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.644200E-03 |
| Normal-vs-Age(41-60Yrs) |
1.74875999999768E-05 |
| Normal-vs-Age(61-80Yrs) |
4.2056000000068E-05 |
| Normal-vs-Age(81-100Yrs) |
1.945510E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.960100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.305600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.717800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.818000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.248400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.933600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.358200E-02 |
| Classical-VS-Follicular |
1.797380E-03 |
| Classical-VS-Other |
1.053600E-01 |
| Classical-VS-Normal |
2.081100E-03 |
| Tall-VS-Follicular |
8.195000E-01 |
| Tall-VS-Other |
4.416800E-01 |
| Tall-VS-Normal |
5.206300E-04 |
| Follicular-VS-Other |
5.569000E-01 |
| Follicular-VS-Normal |
1.8907000000068E-06 |
| Other-VS-Normal |
1.116400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.05839999997581E-06 |
| Normal-vs-N1 |
3.59090000000561E-05 |
| N0-vs-N1 |
4.876600E-01 |
|
|
